Newbridge Financial Services Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4K | Hold |
200
| – | – | ﹤0.01% | 1074 |
|
|
2025
Q1 | $3.91K | Buy |
+200
| New | +$3.91K | ﹤0.01% | 829 |
|
|
2024
Q1 | – | Sell |
-250
| Closed | -$6.81K | – | 1180 |
|
|
2023
Q4 | $6.81K | Hold |
250
| – | – | ﹤0.01% | 809 |
|
|
2023
Q3 | $6.01K | Hold |
250
| – | – | ﹤0.01% | 917 |
|
|
2023
Q2 | $7.98K | Hold |
250
| – | – | ﹤0.01% | 937 |
|
|
2023
Q1 | $7.66K | Hold |
250
| – | – | ﹤0.01% | 974 |
|
|
2022
Q4 | $9.78K | Hold |
250
| – | – | 0.01% | 920 |
|
|
2022
Q3 | $12K | Hold |
250
| – | – | 0.01% | 829 |
|
|
2022
Q2 | $10K | Hold |
250
| – | – | 0.01% | 856 |
|
|
2022
Q1 | $14K | Hold |
250
| – | – | 0.01% | 827 |
|
|
2021
Q4 | $20K | Hold |
250
| – | – | 0.01% | 721 |
|
|
2021
Q3 | $22K | Hold |
250
| – | – | 0.01% | 638 |
|
|
2021
Q2 | $32K | Hold |
250
| – | – | 0.02% | 594 |
|
|
2021
Q1 | $20K | Buy |
+250
| New | +$20K | 0.01% | 689 |
|